Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

Lucia Bailón, Anuska Llano, Samandhy Cedeño, Tuixent Escribà, Miriam Rosás-Umbert, Mariona Parera, Maria Casadellà, Miriam Lopez, Francisco Pérez, Bruna Oriol-Tordera, Marta Ruiz-Riol, Josep Coll, Felix Perez, Àngel Rivero, Anne R. Leselbaum, Ian McGowan, Devi Sengupta, Edmund G. Wee, Tomáš Hanke, Roger ParedesYovaninna Alarcón-Soto, Bonaventura Clotet, Marc Noguera-Julian, Christian Brander, the AELIX002 Study Group

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

44 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial'. Sammen danner de et unikt fingeraftryk.

Immunology and Microbiology